Amplify Startup Spotlight: Arogga

Articles

Arogga focuses on delivering medicine, cheaper and conveniently to your door. The team were part of Amplify Cohort 2, they recently won the Tech in Asia Pitch Night after putting learnings from Amplify into practice. Amplify live sessions start May 4, join by April 26 to get the early bird discount, join now.

I took the feedback from the pitching sessions from both Nesh and Craig, applied to my pitch and deck and actually won the Tech in Asia pitch night recently! This has resulted in some amazing meetings with some investors already.” Rosina Mazumder, Co-Founder, Arogga

Startup:
This is some text inside of a div block.
Vertical:
This is some text inside of a div block.
Market:
This is some text inside of a div block.
Fundraising:
This is some text inside of a div block.
JOIN AMPLIFYJOIN AMPLIFY

ABOUT AROGGA

Tells us about Arogga

We deliver genuine medicine, cheaper and conveniently to your door. We launched in December 2020, have an operating app and have achieved the following:

  • Fulfilled 3000 orders
  • $53k revenue
  • 55% repeat customers

How was the idea for your startup generated?

We spotted a gap in the market and wanted to make an impact in the healthcare industry as it is fragmented and inefficient.  

What problem are you solving?

Getting medicine is a time-consuming, frustrating customer journey where you need to visit several pharmacies in order to get all medicines on your prescription. What is worse, is that 20% of medicine in circulation in Bangladesh is counterfeit.

How does your startup work?

We have an app where you can select medicine, upload a photo of your prescription and place your order. Our in-house pharmacist checks your order, the medicine gets picked and packed, then your parcel is delivered directly to your door.

What’s next for your startup?

We will launch nationwide delivery soon and will launch the sale of higher-margin healthcare products, femcare, vitamins and gym proteins. Then we plan to launch doctor consultations and lab testing services.

THE TEAM

Who is the team behind your startup?

  • Rosina Mazumder, CEO & Co-Founder
  • Yawar Mehboob, CFO & Co-Founder
  • Shamim Hasan, CTO & Co-Founder
  • Fahad Hossain, COO & Co-Founder

Why are you uniquely positioned to solve the problem?

We have an understanding of the pharmacy market and understand the supply of genuine medicine.

What is your superpower?

We saw a gap in the market and decided to quickly take advantage of this. Our superpower is a combination of a great mix of skills in the Co-Founding team and our awesome tech team who have built a brilliant app.

EXPERIENCE WITH THE AMPLIFY

Why did you join Amplify?

Following the interview application to the flagship accelerator program, my team thought the learnings would be really valuable to apply to our startup.

What was your biggest takeaway from Amplify?

The metrics module with Nesh is where I learned the most as well as great feedback from the pitching sessions.

What was the highlight of the program?

Meeting Nesh and Craig during the live sessions and having access to asking them questions.

What sessions did you find the most useful?

The pitching session and the feedback during it was the most valuable.

I took the feedback from the pitching sessions from both Nesh and Craig, applied to my pitch and deck and actually won the Tech in Asia pitch night recently! This has resulted in some amazing meetings with some investors already.

Arogga was part of Amplify, our 6 module program that delivers a how-to guide to raising outside capital and 10x’ing your startup growth. Doors are now open to join Amplify.

If you are interested in connecting with Arogga please reach out to us and we can help facilitate an introduction.

tags:
Articles

Invest in the future

Accelerating Asia invests in startups with scalable technology solutions and revenue generating business models that combine purpose with profit.

Disclaimer

In making an investment decision, investors must rely on their own examination of startups and the terms of the investment including the merits and risks involved. Prospective investors should not construe this content as legal, tax, investment, financial or accounting advice.